BMC
OVID icon

Benin Management Corp’s Ovid Therapeutics OVID Stock Holding History

Benin Management Corp’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1K Hold
19,000
– – 0.01% 150
2026
Q1 		$42.2K Hold
19,000
– – 0.01% 145
2025
Q4 		$31K Buy
+19,000
New +$29.3K 0.01% 138

Other funds holding OVID

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Benin Management Corp's OVID Position: Q2 2026 in Review

Benin Management Corp held its Ovid Therapeutics (OVID) position steady in Q2 2026 at 19,000 shares worth $51.1K. The position accounts for 0.01% of the portfolio, ranked #150.

Benin Management Corp first reported a position in OVID in Q4 2025 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Benin Management Corp held 19,000 shares of Ovid Therapeutics worth $51.1K as of Q2 2026.
  • Benin Management Corp left its Ovid Therapeutics share count unchanged in Q2 2026.
  • Ovid Therapeutics made up 0.01% of Benin Management Corp's portfolio in Q2 2026, its #150 holding.
  • Benin Management Corp first reported a position in Ovid Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 7 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Benin Management Corp's 13F filing for Q2 2026, filed 15 Jul 2026.